Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data Protection (hereinafter referred to as the 'Draft for Comments'), aiming to clarify the...more
4/1/2025
/ Biologics ,
China ,
Clinical Trials ,
Data Protection ,
Drug Pricing ,
Generic Drugs ,
New Regulations ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Regulatory Requirements